No significant difference in overall survival in early stage breast cancer (BC) patients treated with TNFi (alone -/+ cD
Tweet Content
No significant difference in overall survival in early stage breast cancer (BC) patients treated with TNFi (alone -/+ cDMARDs, in 1st year of BC) and cDMARDs in RA. Those on glucocorticoids had worse survival. Suarez-Almazor M, Abst#1675 #ACR23 @RheumNow https://t.co/lnZx3OpuN5
Show on Archive Page
On
Display in Search Results
On
PDQ
Off